Registry for patients with plasma cell disorders

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect data and biological specimens from patients diagnosed with various plasma cell dyscrasias, including multiple myeloma and related conditions. It is a prospective, non-interventional study that will support future research efforts in understanding these diseases. Participants will be monitored over time to gather valuable information that can inform treatment and management strategies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Male or female patients ≥ 18 years of age at the time of informed consent
2. Has been diagnosed with or is suspected to have one of the following:

   1. Monoclonal Gammopathy of Undetermined Significance (MGUS)
   2. Smoldering Multiple Myeloma
   3. Multiple Myeloma
   4. Bony or Soft Tissue Plasmacytoma
   5. Primary Amyloidosis

Exclusion Criteria:

\< 18 years of age

Have not been diagnosed with one of the following:

Monoclonal Gammopathy of Undetermined Significance (MGUS) b.Smoldering Multiple Myeloma c.Multiple Myeloma d.Bony or Soft Tissue Plasmacytoma e.Primary Amyloidosis

Where it's running

• Indiana University Simon Cancer Center
  Indianapolis, Indiana, United States Recruiting

Study contacts

• Principal investigator: Attaya Suvannasankha, MD — Indiana University
• Study coordinator: Attaya Suvannasankha, MD
• Email: asuvanna@iu.edu
• Phone: 317-274-0843

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registry and sample resource for patients with plasma cell disorders

  This study is gathering information from patients with plasma cell disorders like multiple myeloma to see how to improve their treatment and quality of life.

  Recruiting Ohio State University Comprehensive Cancer Center · Columbus, Ohio · NCT01408225

• Goal setting in a school-based sport program for rural middle schoolers

  This project tests whether a 6-week goal-setting program embedded in a school sport program can boost physical activity among 6th–7th graders in two rural Indiana middle schools.

  Recruiting at 2 sites Indiana University · Bloomfield, Indiana and 1 other locations · NCT07859033

• Eye drops Rhopressa vs Timolol to protect nerve cells in glaucoma

  In adults with open-angle glaucoma, this study tests whether Rhopressa helps preserve retinal nerve cells better than Timolol while both lower eye pressure.

  Recruiting Phase 4 Indiana University · Bloomington, Indiana · NCT07847073

• Hydroxychloroquine for AIMSS in breast cancer patients on aromatase inhibitors

  This study tests whether hydroxychloroquine can reduce joint pain in people with breast cancer who are taking aromatase inhibitors and have AIMSS.

  Recruiting Phase 2 Indiana University · Indianapolis, Indiana · NCT07825454

• New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV

  This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.

  Recruiting Indiana University · Lilongwe · NCT07793006

• Sensor-enabled ankle brace for gait and balance testing in adults

  Researchers are testing a modified ankle brace with built-in sensors to see if it accurately measures gait and balance compared with standard equipment in healthy adults.

  Recruiting Indiana University · Bloomington, Indiana · NCT07776223

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.